{
     "PMID": "9413020",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19980219",
     "LR": "20170219",
     "IS": "0143-4179 (Print) 0143-4179 (Linking)",
     "VI": "31",
     "IP": "5",
     "DP": "1997 Oct",
     "TI": "Chronic gestational cocaine treatment decreases oxytocin levels in the medial preoptic area, ventral tegmental area and hippocampus in Sprague-Dawley rats.",
     "PG": "439-43",
     "AB": "We examined the effects of gestational cocaine treatment on oxytocin levels in the whole hippocampus (HIP), ventral tegmental area (VTA), medial preoptic area (MPOA) and amygdala (AMY) in rat dams on postpartum days (PPDs) 1 and 2. Cocaine treatment significantly reduced oxytocin levels in the MPOA within 12-16 h of delivery (PPD 1), but had no significant effect on the other brain areas. Oxytocin was significantly reduced in the HIP and VTA but not in the AMY or MPOA on PPD 2. These data provide the first evidence for the reduction of oxytocin levels in the VTA, HIP and MPOA as a result of gestational cocaine treatment.",
     "FAU": [
          "Johns, J M",
          "Lubin, D A",
          "Walker, C H",
          "Meter, K E",
          "Mason, G A"
     ],
     "AU": [
          "Johns JM",
          "Lubin DA",
          "Walker CH",
          "Meter KE",
          "Mason GA"
     ],
     "AD": "Department of Psychiatry, School of Medicine, University of North Carolina, Chapel Hill 27599-7096, USA. jjohns@css.unc.edu",
     "LA": [
          "eng"
     ],
     "GR": [
          "T32 DA007244/DA/NIDA NIH HHS/United States",
          "R29-DA08456/DA/NIDA NIH HHS/United States",
          "R29 DA008456-05/DA/NIDA NIH HHS/United States",
          "R29 DA008456/DA/NIDA NIH HHS/United States",
          "DA 07244/DA/NIDA NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "PL": "Netherlands",
     "TA": "Neuropeptides",
     "JT": "Neuropeptides",
     "JID": "8103156",
     "RN": [
          "0 (Dopamine Uptake Inhibitors)",
          "50-56-6 (Oxytocin)",
          "I5Y540LHVR (Cocaine)"
     ],
     "SB": "IM",
     "MH": [
          "Amygdala/drug effects",
          "Analysis of Variance",
          "Animals",
          "Brain/*drug effects/metabolism",
          "Cocaine/*pharmacology",
          "Dopamine Uptake Inhibitors/*pharmacology",
          "Female",
          "Hippocampus/drug effects",
          "Oxytocin/*metabolism",
          "Pregnancy",
          "Pregnancy, Animal/*metabolism",
          "Preoptic Area/drug effects",
          "Rats",
          "Rats, Sprague-Dawley",
          "Time Factors",
          "Ventral Tegmental Area/drug effects"
     ],
     "PMC": "PMC3101369",
     "MID": [
          "NIHMS294412"
     ],
     "EDAT": "1997/12/31 00:00",
     "MHDA": "1997/12/31 00:01",
     "CRDT": [
          "1997/12/31 00:00"
     ],
     "PHST": [
          "1997/12/31 00:00 [pubmed]",
          "1997/12/31 00:01 [medline]",
          "1997/12/31 00:00 [entrez]"
     ],
     "AID": [
          "S0143-4179(97)90037-8 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Neuropeptides. 1997 Oct;31(5):439-43.",
     "term": "hippocampus"
}